Impact of phages on two-species bacterial communities

Applied and Environmental Microbiology

Volumn 71, Issue 9, 2005, Pages 5254-5259

  Harcombe, W R ^a   Bull, J J ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; ESCHERICHIA COLI; GLUCOSE;

GROWTH RATES; MONOCULTURE; PHAGE-SENSITIVE BACTERIA; RESISTANT BACTERIA;

BACTERIOLOGY;

GLUCOSE;

BACTERIOPHAGE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIOPHAGE; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ESCHERICHIA COLI; MONOCULTURE; NONHUMAN; POPULATION DENSITY; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SPECIES EXTINCTION;

BACTERIOPHAGE T7; CULTURE MEDIA; ECOSYSTEM; ESCHERICHIA COLI; SALMONELLA PHAGES; SALMONELLA TYPHIMURIUM; T-PHAGES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI B; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 25144463267     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.9.5254-5259.2005     Document Type: Article

References (29)

1. Biswas, B. S. Adhya, P. Washart, B. Paul, A. Trostel, B. Powell, R. Carlton, and C. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210.
2. Buckling, A., and P. Rainey. 2002. Antagonistic coevolution between a bacterium and a bacteriophage. Proc. R. Soc. Lond. B 269:931-936.
3. Bull, J., B. Levin, T. DeRouin, N. Walker, and C. Bloch. 2002. Dynamics of success and failure in phage and antibiotic therapy in experimental infections. BMC Microbiol. 2:35.
4. Chao, L., B. Levin, and F. Stewart. 1977. A complex two-species culture in a simple habitat: an experimental study with bacteria and phage. Ecology 58:369-378.
5. D'Herelle, F. 1926. Bacteriophage and its behavior, p. 490-541. Williams and Wilkins, Baltimore Md.
6. Eaton, M., and S. Bayne-Jones. 1934. Bacteriophage therapy. JAMA 103:1769-1776, 1847-1853, and 1934-1939.
7. Goldberg, E., L. Grinius, and L. Letellier. 1994. Recognition, attachment and injection, p. 347-356. In C. Mathews et al. (ed.), Molecular biology of bacteriophage T4. American Society for Microbiology, Washington, DC.
8. Goodridge, L., and T. Abedon. 2003. Bacteriophage biocontrol and bioprocessing: Application of phage therapy to industry. SIM News 53:254-262.
9. Hantke, K., and V. Braun. 1978. Functional interaction of the tonA/tonB receptor system in Escherichia coli. J. Bacteriol. 135:190-197.
10. Hennes, K., C. Suttle, and A. Chan. 1995. Fluorescently labeled virus probes show that natural virus populations can control the structure of marine microbial communities. Appl. Environ. Microbiol. 61:3623-3627.
11. Huff, W., G. Huff, N., Rath, J. Balog, and A. Donoghue. 2002. Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poult. Sci. 81:1486-1491.
12. Lenski, R., and B. Levin. 1985. Constraints on the coevolution of bacteria and virulent phage: a model, some experiments and predictions for natural communities. Am. Nat. 125:585-602.
13. Lenski, R. 1988. Dynamics of interactions between bacteria and virulent bacteriophage. Adv. Microb. Ecol. 10:1-44.
14. Levin, B., and J. Bull. 1996. Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 147:881-898.
15. Levin, B., and J. Bull. 2004. Population and evolutionary dynamics of phage therapy. Nat. Rev. Microbiol. 2:166-173.
16. Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, Y. Shen, Z. Jin, S. Fujimoto, M. Nasimuzzaman, H. Wakiguchi, S. Sughiara, T. Suguira, S. Koda, A. Muraoka, and S. Imai, 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187:613-624.
17. Merril, C., B. Biswas, R. Carlton, N. Jensen, G. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
18. Merril, C., D. Scholl, and S. Adhya. 2003. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2:489-497.
19. Miller, J. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
20. Mizoguchi, K., M. Morita, C. Fischer, M. Yoichi, Y. Tanji, and H. Unno, 2002. Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl. Environ. Microbiol. 69:170-176.
21. Nakai, T., and S. Park. 2002. Bacteriophage therapy of infectious diseases in aquaculture. Res. Microbiol. 153:13-18.
22. Proctor, L., and J. Fuhrman. 1990. Viral mortality of marine bacteria and cyanobacteria. Nature 343:60-62.
23. Scholl, D., J. Kieleczawa, P. Kemp, J. Rush, C. Richardson, C. Merril, S. Adyha, and I. Molineux. 2004. Genomic analysis of bacteriophages SP6 and K1-5, an estranged subgroup of the T7 supergroup. J. Mol. Biol. 335:1151-1171.
24. Smith, H., and M. Huiggins. 1983. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves piglets and lambs. J. Gen. Microbiol. 129:2659-2675.
25. Soothill, J. 1992. Treatment of experimental infections of mice with bacteriophage. J. Med. Microbiol. 37:258-262.
26. Summers, W. 2002. Bacteriophage therapy. Annu. Rev. Microbiol. 55:437-471.
27. Sutherland, I., K. Hughes, L. Skillman, and K. Tait. 2004. The interaction of phage and biofilms. FEMS Microbiol. Lett. 232:1-6.
28. Suttle, C., and A. Chan. 1994. Dynamics and distribution of cyanophages and their effect on marine Synechococcus spp. Appl. Environ. Microbiol. 60:3167-3174.
29. Waterbury, J., and F. Valois. 1993. Resistance to cooccurring phages enables marine Synechococcus communities to coexist with cyanophage abundant in seawater. Appl. Environ. Microbiol. 59:3393-3399.